作者: Patrick Y Wen , Jan Drappatz
DOI: 10.1586/14737175.6.10.1447
关键词: Radiation therapy 、 Medical physics 、 Radiosurgery 、 Targeted Molecular Therapy 、 Medicine 、 Intensive care medicine 、 Refractory 、 MEDLINE
摘要: Although advances in surgery, radiation therapy and stereotactic radiosurgery have significantly improved the treatment of meningiomas, there remains an important subset patients who remain refractory to conventional therapy. Treatment with chemotherapeutic agents such as hydroxyurea alpha-interferon has provided minimal benefit. In this review, role newly emerging novel therapies for a focus on targeted molecular agents, will be discussed.